estrogen replacement therapy reduces the risk of colorectal cancer

December 1999

There's increasing evidence that estrogen replacement therapy reduces the risk of colorectal cancer.

This benefit started showing up several years ago.

Now it seems that estrogen lowers the risk of colorectal cancer by about a third.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

highlighting the value of pharmacists' interventions
whether patients on SSRIs can use one of the "triptans" for migraines
Comtan (entacapone), a new drug for advanced Parkinson's disease
Diabetes many patients with type 1 diabetes don't realize when their blood sugar is too low to drive safely
Women's Health estrogen replacement therapy reduces the risk of colorectal cancer
Women's Health PremesisRx, a new prescription product for morning sickness
Ophthalmology more people taking lutein
Infectious Diseases two new flu drugs, Tamiflu (oseltamivir) and Relenza (zanamivir)
Infectious Diseases Do all the new antibacterial soaps, lotions, and gels really help prevent colds and flu
Rheumatoid Arthritis Enbrel (etanercept) or Remicade (infliximab) for rheumatoid arthritis
natural products for the cold and flu season
Cardiology low-molecular-weight heparins
Cardiology amiodarone (Cordarone IV) to help resuscitate cardiac arrest victims
Lots of people are using magnets
Practice taking their quinolone antibiotic, Raxar (grepafloxacin) off the market